BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3365275)

  • 1. New pharmacological data on the bronchospasmolytic activity of bamifylline.
    Berti F; Magni F; Rossoni G; Schiantarelli P; Bongrani S; Pasargiklian R
    Arzneimittelforschung; 1988 Jan; 38(1):40-4. PubMed ID: 3365275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activity of bamifylline on lung anaphylaxis: in vitro studies.
    Berti F; Magni F; Rossoni G; Bongrani S; Schiantarelli P
    Pharmacol Res; 1990; 22(2):143-50. PubMed ID: 1691847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LG 30435, a new potential antiasthmatic agent.
    Berti F; Daffonchio L; Magni F; Omini C; Rossoni G; Subissi A
    Eur Respir J; 1989 Oct; 2(9):868-73. PubMed ID: 2806514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
    Evangelista S; Ballati L; Boni P; Castellucci A; Perretti F; Tramontana M; Toja E
    Arzneimittelforschung; 1995 May; 45(5):569-75. PubMed ID: 7612055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilating activity of mequitazine.
    Rossoni G; Omini C; Folco GC; Vigano T; Brunelli G; Berti F
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):128-40. PubMed ID: 6587833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig.
    Berti F; Rossoni G; Buschi A; Robuschi M; Villa LM
    Arzneimittelforschung; 1990 Sep; 40(9):1011-6. PubMed ID: 1981969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator and other pharmacological activities of R-836 (2,5-diethyl-7-(4-thiomorpholino)-1,2,4-triazolo[1,5-c]pyrimidin e).
    Swingle KF; Hammerbeck DM; Schmid JR; Stelzer VL; Reiter MJ; Peterson AM; Wade JJ
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):255-71. PubMed ID: 3592866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Sickels BD; Woeppel SL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF.
    Franzone JS; Cirillo R; Biffignandi P
    Eur J Pharmacol; 1989 Jun; 165(2-3):269-77. PubMed ID: 2776832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
    Ohashi M; Uno T; Nishino K
    Int Arch Allergy Immunol; 1993; 101(3):288-96. PubMed ID: 8324390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of BAY u3405-thromboxane A2 receptor antagonist, on biphasic airway responses induced by platelet-activating factor in actively sensitized guinea pigs].
    Arima M; Yukawa T; Fukuda T; Makino S
    Arerugi; 1995 Jul; 44(7):701-7. PubMed ID: 7575136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple mechanisms of xanthine actions on airway reactivity.
    Howell RE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1008-14. PubMed ID: 2175791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
    Berti F; Omini C; Rossoni G; Braquet P
    Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
    Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
    Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
    Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
    Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of theophylline on both bronchoconstriction and plasma extravasation induced by acetaldehyde in guinea-pigs.
    Berti F; Rossoni G; Buschi A; Villa LM; Trento F; Della Bella D; Bagolan M
    Arzneimittelforschung; 1994 Mar; 44(3):323-6. PubMed ID: 7514875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isbufylline, a new xanthine derivative, inhibits airway hyperresponsiveness and airway inflammation in guinea pigs.
    Manzini S; Perretti F; Abelli L; Evangelista S; Seeds EA; Page CP
    Eur J Pharmacol; 1993 Nov; 249(3):251-7. PubMed ID: 7507057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the lipoxygenase inhibitor N-hydroxy-N-(6-methoxy-3,4-dihydro-2-naphthylmethyl)urea on bronchoconstriction and lung vascular permeability in anaphylactic guinea pigs.
    Geist C; Schneider J; Zimmer O
    Arzneimittelforschung; 1995 Feb; 45(2):155-8. PubMed ID: 7710438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.